{"Symbol": "ARAY", "AssetType": "Common Stock", "Name": "Accuray Incorporated", "Description": "Accuray Incorporated designs, develops and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa and the rest of the Asia Pacific region. The company is headquartered in Sunnyvale, California.", "CIK": "1138723", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL DEVICES", "Address": "1240 DEMING WAY, MADISON, WI, UNITED STATES, 53717-1954", "OfficialSite": "https://www.accuray.com", "FiscalYearEnd": "June", "LatestQuarter": "2025-12-31", "MarketCapitalization": "62066000", "EBITDA": "-2187000", "PERatio": "None", "PEGRatio": "0.08", "BookValue": "0.442", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-0.31", "RevenuePerShareTTM": "3.889", "ProfitMargin": "-0.0815", "OperatingMarginTTM": "0.0373", "ReturnOnAssetsTTM": "-0.0118", "ReturnOnEquityTTM": "-0.703", "RevenueTTM": "436969000", "GrossProfitTTM": "121689000", "DilutedEPSTTM": "-0.31", "QuarterlyEarningsGrowthYOY": "-0.962", "QuarterlyRevenueGrowthYOY": "0.168", "AnalystTargetPrice": "2.525", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "2", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "94.34", "PriceToSalesRatioTTM": "0.142", "PriceToBookRatio": "1.162", "EVToRevenue": "0.446", "EVToEBITDA": "15.07", "Beta": "1.15", "52WeekHigh": "2.318", "52WeekLow": "0.5", "50DayMovingAverage": "0.841", "200DayMovingAverage": "1.291", "SharesOutstanding": "113341000", "SharesFloat": "115017000", "PercentInsiders": "4.107", "PercentInstitutions": "68.054", "DividendDate": "None", "ExDividendDate": "None"}